Chase Lopriore

Director, Hepion Pharmaceuticals, Inc.

Companies

Hepion Pharmaceuticals, Inc.VP, Corp. Dev. Aug 21, 2026 to now¹
Hepion Pharmaceuticals, Inc.Board member May 26, 2026 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Hepion Pharmaceuticals, Inc. HEPA1,250,000 shares³$127.6K at $0.10May 26, 2026

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHepion Pharmaceuticals, Inc., VP, Corp. Dev.
2
SEC EDGARHepion Pharmaceuticals, Inc., Board member
3
SEC EDGARHepion Pharmaceuticals, Inc. shares after the filing of May 26, 2026